http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-539071-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae10212794160b34478f0d05b6ab6fd7 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
filingDate | 2001-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b4ae9fa9acfbfbd99d8d9d7a90fda50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d78b65f00ee879d6324dd9db3585e2fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_028699d20006bf51b609b15d01db457c |
publicationDate | 2008-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NZ-539071-A |
titleOfInvention | Pharmaceutically active isoindoline derivatives |
abstract | Disclosed is a compound of formula II wherein: a) the compound is diasterometrically and enantiomerically pure and the configuration of the C-3 carbon and the configuration of the C-5 carbon is S, S or S, R or R,S or R,R, or b) the compound of formula II is a mixture of any two or more isomers. Also disclosed is a pharmaceutically composition comprising a pharmaceutically effective dose of formula II and a pharmaceutically acceptable carrier, excipient, diluent and/or adjuvant. |
priorityDate | 2000-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 322.